Suchergebnisse - "Businaro, Pietro"

PubPharm (7)

1

MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria : a clinical-laboratory assessment

enthalten in: Journal of neurology | 2024

von Risi, M. | Greco, G. | Masciocchi, S. | +11

2

Autoimmune encephalitis : what the radiologist needs to know

enthalten in: Neuroradiology | 2024

von Sanvito, F. | Pichiecchio, A. | Paoletti, M. | +13

3

General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis

enthalten in: Critical reviews in clinical laboratory sciences | 2024

von Masciocchi, S. | Businaro, P. | Scaranzin, S. | +3

4

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG) : a randomised, double-blind, placebo-controlled, adaptive phase 3 study

enthalten in: The Lancet. Neurology | 2023

von Bril, V. | Drużdż, A. | Grosskreutz, J. | +113

CommentIn: Lancet Neurol. 2023 May;22(5):368-369. - PMID 37059497

5

Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2023

von Spagni, G. | Gastaldi, M. | Businaro, P. | +8

6

Movement disorders associated with neuronal antibodies : a data-driven approach

enthalten in: Journal of neurology | 2022

von Sturchio, A. | Dwivedi, A. | Gastaldi, M. | +8

7

Improving laboratory diagnostics in myasthenia gravis

enthalten in: Expert review of molecular diagnostics | 2021

von Gastaldi, M. | Scaranzin, S. | Businaro, P. | +4

1
[1]